M&A

News

The battle for obesity drug developer Metsera rumbles on, with Pfizer reported to have now matched Novo Nordisk's $10 billion offer.

News

A $390m merger of two pioneers of psychedelic medicines has completed to create AtaiBeckley, with a pipeline of candidates for mental illnesses.

News

Metsera has now received new takeover bids from both Pfizer and Novo Nordisk, and has plumped for a sweetened $10bn offer from the latter.

News

Metsera says Novo Nordisk's takeover offer is superior to one filed by Pfizer, and the latter files a new lawsuit to try to force their deal through.

News

Facing talc and Tylenol litigation, J&J consumer health spinout Kenvue has agreed to a takeover by consumer goods giant Kimberly-Clark.

News

Pfizer has filed a lawsuit to block a rival, higher bid for obesity therapy developer Metsera from Novo Nordisk, claiming it is anti-competitive.